Is it time to revisit a role for antithrombotic therapy in asphyxia neonatorum?
Clark
Robert
R
Carcillo
Joseph A
JA
D000990:Antithrombin III / Q000037:antagonists & inhibitors*; D001237:Asphyxia / Q000150:complications; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000097:blood* / Q000209:etiology; D007231:Infant, Newborn; D011486:Protein C / Q000037:antagonists & inhibitors*; D017293:Protein S / Q000037:antagonists & inhibitors*; D013927:Thrombosis / Q000209:etiology
D005343:Fibrinolytic Agents; D011486:Protein C; D017293:Protein S; D000990:Antithrombin III